Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Moghetti

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
The Journal of Clinical Endocrinology and Metabolism|April 13, 1999
Spironolactone, but not flutamide, administration prevents bone loss in hyperandrogenic women treated with gonadotropin-releasing hormone agonistP Moghetti, R Castello, N Zamberlan, et al.
Fertility and Sterility|September 1, 1995
Flutamide in the treatment of hirsutism: long-term clinical effects, endocrine changes, and androgen receptor behaviorP Moghetti, R Castello, C Negri, et al.
Journal of Endocrinological Investigation|January 1, 1992
Studies on the mechanism of action of sulphonylureas in type II diabetic subjects: gliquidoneE Bonora, P Moghetti, M Querena, et al.
The Journal of Clinical Endocrinology and Metabolism|January 14, 2000
Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trialP Moghetti, F Tosi, A Tosti, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|March 1, 1993
Mononuclear leukocytes from obese patients with type II diabetes have reduced activity of hexokinase, 6-phosphofructokinase and glucose-6-phosphate dehydrogenaseM Muggeo, P Moghetti, M Querena, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|March 1, 1982
[Insulin receptors in syndromes involving acanthosis nigricans and severe insulin resistance]M Muggeo, V Businaro, P P Faronato, et al.
Acta Diabetologica Latina|October 1, 1990
Plasma concentrations of glucagon during hyperglycemic clamp with or without somatostatin infusion in obese subjectsE Bonora, P Moghetti, V Cacciatori, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|November 1, 1990
Normal inhibition by somatostatin of glucose-stimulated B cell secretion in the obese subjectsE Bonora, P Moghetti, C Zancanaro, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1996
Power spectral analysis of heart rate in hyperthyroidismV Cacciatori, F Bellavere, A Pezzarossa, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|February 26, 2018
Association of free-living physical activity measures with metabolic phenotypes in type 2 diabetes at the time of diagnosis. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS)M Dauriz, E Bacchi, L Boselli, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
The Journal of Clinical Endocrinology and Metabolism|April 13, 1999
Spironolactone, but not flutamide, administration prevents bone loss in hyperandrogenic women treated with gonadotropin-releasing hormone agonistP Moghetti, R Castello, N Zamberlan, et al.
Fertility and Sterility|September 1, 1995
Flutamide in the treatment of hirsutism: long-term clinical effects, endocrine changes, and androgen receptor behaviorP Moghetti, R Castello, C Negri, et al.
Journal of Endocrinological Investigation|January 1, 1992
Studies on the mechanism of action of sulphonylureas in type II diabetic subjects: gliquidoneE Bonora, P Moghetti, M Querena, et al.
The Journal of Clinical Endocrinology and Metabolism|January 14, 2000
Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trialP Moghetti, F Tosi, A Tosti, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|March 1, 1993
Mononuclear leukocytes from obese patients with type II diabetes have reduced activity of hexokinase, 6-phosphofructokinase and glucose-6-phosphate dehydrogenaseM Muggeo, P Moghetti, M Querena, et al.
Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Societa Italiana Di Dermatologia E Sifilografia|March 1, 1982
[Insulin receptors in syndromes involving acanthosis nigricans and severe insulin resistance]M Muggeo, V Businaro, P P Faronato, et al.
Acta Diabetologica Latina|October 1, 1990
Plasma concentrations of glucagon during hyperglycemic clamp with or without somatostatin infusion in obese subjectsE Bonora, P Moghetti, V Cacciatori, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|November 1, 1990
Normal inhibition by somatostatin of glucose-stimulated B cell secretion in the obese subjectsE Bonora, P Moghetti, C Zancanaro, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1996
Power spectral analysis of heart rate in hyperthyroidismV Cacciatori, F Bellavere, A Pezzarossa, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|February 26, 2018
Association of free-living physical activity measures with metabolic phenotypes in type 2 diabetes at the time of diagnosis. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS)M Dauriz, E Bacchi, L Boselli, et al.
Pageof 7